NCT02493478 Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
| NCT ID | NCT02493478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Failed or Difficult Intubation, Sequela |
| Study Type | OBSERVATIONAL |
| Enrollment | 150,000 participants |
| Start Date | 2010-03 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150,000 participants in total. It began in 2010-03 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Advanced airway interventions are common high risk, high stakes events for children in intensive care units (ICU) and emergency departments (ED), with risk for life and health threatening consequences.
Eligibility Criteria
Inclusion Criteria: * Primary advanced airway events (on patients of all ages) in the PICU, CICU, NICU, DR and ED including: Tracheal Intubation, Laryngeal mask placement, Emergency tracheostomy and/or cricothyrotomy * Failed extubation attempts or unplanned extubations that require re-intubation will be considered a new primary intubation. Exclusion Criteria: * Primary advanced airway events (tracheal intubations, laryngeal mask placement, emergency tracheostomy and/or cricothyrotomy) in the Operating Suites.
Contact & Investigator
Vinay Nadkarni, MD. MS
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT02493478 clinical trial?
This trial is open to participants of all sexes, studying Failed or Difficult Intubation, Sequela. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02493478 currently recruiting?
Yes, NCT02493478 is actively recruiting participants. Contact the research team at buffmanh@chop.edu for enrollment information.
Where is the NCT02493478 trial being conducted?
This trial is being conducted at Birmingham, United States, Phoenix, United States, Little Rock, United States, Madera, United States and 11 additional locations.
Who is sponsoring the NCT02493478 clinical trial?
NCT02493478 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Vinay Nadkarni, MD. MS at Children's Hospital of Philadelphia. The trial plans to enroll 150,000 participants.